Protein Assays Market to be Worth $4.36 Billion by 2031

Protein Assays Market by Type (Dye-based, Copper-based) Technology (Fluorescence, Absorbance, Colorimetric) Offering (Reagent, Kit, Instrument) Application (R&D, Drug Discovery, Diagnostics) End User (Pharmaceutical, Hospital) – Global Forecast to 2031

Meticulous Research^®—a leading global market research company, published a research report titled, ‘Protein Assays Market by Type (Dye-based, Copper-based) Technology (Fluorescence, Absorbance, Colorimetric) Offering (Reagent, Kit, Instrument) Application (R&D, Drug Discovery, Diagnostics) End User (Pharmaceutical, Hospital) – Global Forecast to 2031’

According to this latest publication from Meticulous Research^®, the global protein assays market is projected to reach $4.36 billion by 2031 at a CAGR of 9.3% from 2024 to 2031. The growth of this market can be attributed to various factors, such as increasing pharmaceutical R&D expenditure, rising use of protein assays in drug discovery & development, growth in the food & beverage industry, and rising use of protein assays in clinical diagnostics tests. However, the high cost of protein assay equipment restrains market growth.

Furthermore, increasing focus on proteomics research and the use of protein assays in personalized medicine is expected to offer market growth opportunities. However, the shortage of skilled professionals and high chances of error with complex samples are a major challenge for the market’s growth.

Key Players

The key players operating in the global protein assays market are Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Revvity, Inc. (U.S.), Merck KGaA (Germany), Abcam plc (U.K.), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), Promega Corporation (U.S.), Cell Signaling Technology, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), and Novus Biologicals (U.S.).

Protein Assays Market: Future Outlook

The global protein assays market is segmented by Offering (Reagents & Kits and Instruments & Accessories), Type (Dye-based Assay, Copper-based Assay, and Other Assay Types), Technology (Fluorescence-based Protein Assay, Absorbance-based Protein Assay, and Colorimetric-based Protein Assay), Application (Drug Discovery, Research & Development, Clinical Diagnosis, and Other Applications), End User (Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Food & Beverage Companies, Other End Users), and Geography. The study also evaluates industry competitors and analyzes their market shares at the global and regional levels.

Among all the offerings studied in this report, in 2024, the reagents & kits segment is expected to account for the largest share of the protein assays market. The largest share of the segment is attributed to the increasing use of protein assays reagents & kits for accurate and faster results. Additionally, the wide availability of consumables, recurring use of protein assay kits, and increasing adoption of these kits by researchers to estimate protein concentration in unknown samples are contributing to the largest share of the segment.

Among all the types studied in this report, in 2024, the dye-based assay segment is expected to account for the largest share of the protein assays market. The large market share of this segment is attributed to the rapid results with the dye-based assays enabling testing of a high number of samples in a short time, and the test uses visible light for the detection, so no special instrumentation is required. Additionally, the reagents used in the assays do not cross-react with each other thus, the reliability of the method increases, and increasing use of dye-binding assays in the determination of residual protein content in biological processes such as cell lysis is contributing to the largest share of the segment.

Among all the technologies studied in this report, in 2024, the absorbance-based protein assay segment is expected to account for the largest share of the protein assays market. The largest share of the segment is attributed to the absorbance method is an accepted choice for researchers, has less sample consumption, is simple to perform, and requires no additional or hazardous reagents or standards. Additionally, absorbance is considered the best measurement method for the quantification of pure protein samples, further supporting the largest share of the segment.

Among all the applications studied in this report, in 2024, the drug discovery segment is expected to account for the largest share of the protein assays market. The largest share of the segment is attributed to the increased use of protein assay in life science research, as quantification of proteins is a primary requirement for many downstream processes such as structural analysis, immunochemical techniques, protein separation, and chromatographic techniques, which can further be employed into drug discovery & development process.

Among all end users studied in this report, in 2024, the pharmaceutical & biotechnology segment is expected to account for the largest share of the protein assays market. The large market share of this segment is attributed to the growing number of research and clinical laboratories, increased investments in R&D, and rising funding for pharmaceutical research. The rising demand for new drugs and therapies is driving an increase in funding for research laboratories, consequently creating a higher demand for protein assays. For instance, NIH funding has witnessed an increase from USD 42 billion in 2021 to USD 45 billion in 2022 for research purposes (Source: Congressional Research Service).

This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and the Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), and the Middle East & Africa.

Among all regions studied in this report, in 2024, North America is expected to account for the largest share of the protein assays market. North America’s major market share is attributed to the presence of key players, well-established research and clinical laboratories, and substantial spending on R&D by pharmaceutical and biotechnology companies. Additionally, the expansion of research and clinical laboratories by the key players is supporting the largest regional share. For instance, in October 2022, Thermo Fisher Scientific Inc. (U.S.) is expanding its clinical research lab in Kentucky, U.S., with an investment of USD 59 million.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5803

Key questions answered in the report-

Which are the high-growth market segments in terms of offering, type, technology, application, end user, and region/country?
What was the historical market for protein assays across the globe?
What are the market forecasts and estimates for the period 2024–2031?
What are the major drivers, restraints, challenges, opportunities, and trends in the global protein assays market?
Who are the major players in the global protein assays market?
What is the competitive landscape like, and who are the market leaders in the global protein assays market?
What are the recent developments in the protein assays market?
What are the different strategies adopted by the major players in the protein assays market?
What are the geographical trends and high growth regions/countries?

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research